Shares of pharmacy benefit managers extended losses Tuesday after Pfizer CEO Albert Bourla said President-elect Donald Trump is "very committed" to reforming drug-industry middlemen. Bloomberg News' John Tozzi speaks with Sonali Basak on "Bloomberg Markets."

Bloomberg videos, provided by MT Newswires